Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Kidney Transplantation

  Free Subscription


Articles published in Br J Clin Pharmacol

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    January 2019
  1. SALLUSTIO BC, Noll BD, Coller JK, Tuke J, et al
    Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the first month following renal transplantation.
    Br J Clin Pharmacol. 2019 Jan 28. doi: 10.1111/bcp.13880.
    PubMed     Text format     Abstract available


    December 2018
  2. ZHANG HX, Sheng CC, Liu LS, Luo B, et al
    Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
    Br J Clin Pharmacol. 2018 Dec 29. doi: 10.1111/bcp.13850.
    PubMed     Text format     Abstract available


  3. ANDREWS LM, Hesselink DA, van Schaik RHN, van Gelder T, et al
    A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
    Br J Clin Pharmacol. 2018 Dec 14. doi: 10.1111/bcp.13838.
    PubMed     Text format     Abstract available


    November 2018
  4. CAMPAGNE O, Mager DE, Brazeau D, Venuto RC, et al
    The Impact of Tacrolimus Exposure on Extrarenal Adverse Effects in Adult Renal Transplant Recipients.
    Br J Clin Pharmacol. 2018 Nov 10. doi: 10.1111/bcp.13811.
    PubMed     Text format     Abstract available


    September 2018
  5. ZWART TC, Gokoel SRM, van der Boog PJM, de Fijter JW, et al
    herapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device.
    Br J Clin Pharmacol. 2018 Sep 3. doi: 10.1111/bcp.13755.
    PubMed     Text format     Abstract available


    July 2018
  6. MD DOM ZI, Coller JK, Carroll RP, Tuke J, et al
    Mycophenolic Acid Concentrations in Peripheral Blood Mononuclear Cells are Associated with the Incidence of Rejection in Renal Transplant Recipients.
    Br J Clin Pharmacol. 2018 Jul 2. doi: 10.1111/bcp.13704.
    PubMed     Text format     Abstract available


    April 2018
  7. LIN XB, Li ZW, Yan M, Zhang BK, et al
    Population Pharmacokinetics of Voriconazole and CYP2C19 Polymorphisms for Optimizing Dosing Regimens in Renal Transplant Recipients.
    Br J Clin Pharmacol. 2018 Apr 1. doi: 10.1111/bcp.13595.
    PubMed     Text format     Abstract available


    January 2018
  8. VAN SLOTEN TT, de Klaver PAG, van den Wall Bake AWL
    Co-administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49-year-old man.
    Br J Clin Pharmacol. 2018;84:208-210.
    PubMed     Text format     Abstract available


    September 2017
  9. MAO JJ, Jiao Z, Yun HY, Zhao CY, et al
    External Evaluation of Population Pharmacokinetic Models for Cyclosporine in Adult Renal Transplant Recipients.
    Br J Clin Pharmacol. 2017 Sep 11. doi: 10.1111/bcp.13431.
    PubMed     Text format     Abstract available


  10. MILLAN O, Budde K, Sommerer C, Aliart I, et al
    Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
    Br J Clin Pharmacol. 2017 Sep 7. doi: 10.1111/bcp.13399.
    PubMed     Text format     Abstract available


    July 2017
  11. BREMER S, Vethe NT, Skauby M, Kasbo M, et al
    NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation.
    Br J Clin Pharmacol. 2017 Jul 7. doi: 10.1111/bcp.13367.
    PubMed     Text format     Abstract available


    June 2017
  12. VANHOVE T, Hasan M, Annaert P, Oswald S, et al
    Pretransplant 4beta-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.
    Br J Clin Pharmacol. 2017 Jun 11. doi: 10.1111/bcp.13343.
    PubMed     Text format     Abstract available


  13. STORSET E, Hole K, Midtvedt K, Bergan S, et al
    Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'.
    Br J Clin Pharmacol. 2017;83:1357-1358.
    PubMed     Text format    


  14. VANHOVE T, Annaert P, Kuypers DRJ
    Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'.
    Br J Clin Pharmacol. 2017;83:1353-1356.
    PubMed     Text format    


  15. STORSET E, Hole K, Midtvedt K, Bergan S, et al
    Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance.
    Br J Clin Pharmacol. 2017;83:1350-1352.
    PubMed     Text format    


    April 2017
  16. KNOPS N, Herman J, van Dyck M, Ramazani Y, et al
    Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.
    Br J Clin Pharmacol. 2017;83:863-874.
    PubMed     Text format     Abstract available


    March 2017
  17. RIVOLI L, Vliegenthart AD, de Potter CM, van Bragt JJ, et al
    The effect of renal dysfunction and haemodialysis on circulating liver specific miR-122.
    Br J Clin Pharmacol. 2017;83:584-592.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: